Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 8/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | LTA4H | P09960 | 3/20 | 0.38 |
| ▸ | MCHR1 | Q99705 | 4/20 | 0.38 |
| ▸ | MCHR2 | Q969V1 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1729474 | 0.84 | HRH3 (0.57) | HRH3KCNH2 | |
| SCHEMBL1729757 | 0.83 | LTA4H (0.53) | HRH3MEN1KMT2ALTA4HMCHR1 | |
| SCHEMBL1727398 | 0.79 | NPC1 (0.49) | HRH3LTA4HMCHR1MCHR2KCNH2 | |
| SCHEMBL1728694 | 0.77 | KDM4E (0.56) | HRH3KMT2ALTA4HMCHR1MCHR2 | |
| SCHEMBL1727374 | 0.77 | LTA4H (0.46) | HRH3MEN1KMT2ALTA4HMCHR1 | |
| SCHEMBL6081377 | 0.75 | LTA4H (0.44) | HRH3LTA4HMCHR1MCHR2KCNH2 | |
| SCHEMBL6081517 | 0.75 | LTA4H (0.45) | HRH3LTA4HMCHR1MCHR2KCNH2 | |
| SCHEMBL1728674 | 0.75 | ALDH1A1 (0.60) | HRH3MEN1KMT2ALTA4HMCHR1 | |
| SCHEMBL6081914 | 0.74 | MCHR1 (0.48) | HRH3LTA4HMCHR1MCHR2KCNH2 | |
| SCHEMBL6081905 | 0.74 | MCHR1 (0.48) | HRH3LTA4HMCHR1MCHR2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1551810-B1 | DIARYL-SUBSTITUTED CYCLIC UREA DERIVATIVES HAVING AN MCH-MODULATORY EFFECT | SANOFI AVENTIS DEUTSCHLAND (DE) | 2011-11-30 | — | — | EP | disclosed |
| US-7141561-B2 | Substituted diaryl heterocycles, process for their preparation and their use as medicaments | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2006-11-28 | — | — | US | disclosed |